Pfizer, Moderna to Expand Vaccine Studies of Kids 5 to 11: Report

The U.S. Food and Drug Administration has urged Pfizer and Moderna to expand their clinical trials for children 5 to 11 years old, amid cases of heart inflammation among those under 30 years of age who had been vaccinated, The New York Times reported Monday.